2nd Quarter - Report

SIDLEY AUSTIN LLP for SUNOVION PHARMACEUTICALS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D

LobbyistCovered position, as disclosed
PATRICIA LOUISE DELOATCHE Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis
STEPHANIE P HALES N/A
DARON WATTS N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.